2DG

Thomas P Sutula1, Nathan B Fountain2

  • 1Department of Neurology, University of Wisconsin, Madison WI, USA; Hexokine Therapeutics, Inc. Madison WI, USA.

Epilepsy & behavior : E&B
|September 6, 2024
PubMed
概括

2-deoxy-D-glucose (2DG) 显示出作为抗发作药物的前景. 临床前毒理学研究表明,静脉注射2DG可能安全用于急性治疗状态和急性重复性发作.